What are best practices for engaging with multidisciplinary colleagues to ensure patients with earlier stage NSCLC are being appropriately considered for novel adjuvant therapies?
How are your teams effectively evaluating and counseling patients to ensure they are prepared for potential extended adjuvant treatment approaches? Is that best done pre-operatively vs post-operatively?
Answer from: Medical Oncologist at Academic Institution
Treatment of early stage or locally advanced stage NSCLC truly requires a cohesive multidisciplinary team and consistent messaging. Many, if not all, of these cases should be discussed prospectively at a multidisciplinary tumor board. It is also important to set expectations with patients up front a...
Sign in or Register to read more
Answer from: Medical Oncologist at Academic Institution
Multi-disciplinary care for most patients with Stage 1-3 NSCLC is standard of care. (Perhaps also for metastatic NSCLC or SCLC, but that’s a whole other story!) The discussion regarding treatment planning should occur before, and not after, the patient’s local treatment has been initiate...
Answer from: at Academic Institution
All post-operative lung resection patients are discussed at our multidisciplinary tumor board. As a collective group and especially with input from medical oncology colleagues almost all patients will be considered for adjuvant therapy if they are candidates.
Answer from: Medical Oncologist at Community Practice
All of our patients, even those with metastatic disease, are presented in our weekly multi-disciplinary thoracic conference. Immediately after the conference, the patient is seen in clinic by those specialists (i.e. surgery, medical oncology, radiation oncology, etc.) who will need to be involved mo...